Arcadis NV (LON:0N6B)
50.40
+1.46 (2.98%)
At close: Oct 24, 2025
Arcadis NV Revenue
Arcadis NV had revenue of 2.45B EUR in the half year ending June 30, 2025, a decrease of -0.97%. This brings the company's revenue in the last twelve months to 4.94B, down -2.02% year-over-year. In the year 2024, Arcadis NV had annual revenue of 5.00B, down -0.16%.
Revenue (ttm)
4.94B EUR
Revenue Growth
-2.02%
P/S Ratio
0.93
Revenue / Employee
153.97K EUR
Employees
32,059
Market Cap
3.94B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.00B | -8.00M | -0.16% |
| Dec 31, 2023 | 5.00B | 974.07M | 24.18% |
| Dec 31, 2022 | 4.03B | 650.45M | 19.25% |
| Dec 31, 2021 | 3.38B | 75.28M | 2.28% |
| Dec 31, 2020 | 3.30B | -170.16M | -4.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |